Amazon Oxygen Concentrators

Capping trade margin on O2 concentrators resulted in consumer savings: Govt | Elocationfinder

Capping the trade margin on oxygen concentrators by the government has resulted in ensuring consumer savings as the price of the critical device has come down, the Ministry of Chemicals and Fertilizers said on Friday.

On June 3, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on oxygen concentrators at 70 per cent on the price to distributor (PTD) level.

In accordance with it, “a total of 104 manufacturers / importers of oxygen concentrators have submitted revised MRP for 252 products/brands,” it said.

Downward revision in price by up to 54 per cent has been reported in 70 brands, showing reduction in maximum retail price by up to Rs 54,337 per unit. Further, 58 brands have reported price reduction of up to 25 per cent and 11 brands reported price reduction of 26-50 per cent, the statement said.

“Out of 252 products/brands reported, 18 products/brands reported by the domestic manufacturers did not show any decline in prices,” it added.

The trade margin rationalisation for oxygen concentrators has resulted in ensuring consumer savings by eliminating unreasonable profit margins in imported products, the Ministry said.

The revised MRP effective from June 9, 2021 on all the brands and specifications has been shared with the State Drug Controllers for strict monitoring and enforcement, it added.

“In order to monitor availability, the manufacturers / importers of oxygen concentrators have been directed to submit monthly stock details,” the statement said.

Oxygen concentrator is a non-scheduled drug and presently under the voluntary licensing framework of Central Drugs Standard Control Organisation (CDSCO).

In February 2019, NPPA had successfully capped the trade margin on anti-cancer drugs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Leave a Reply

Your email address will not be published. Required fields are marked *